Core Insights - HeartCore Enterprises, Inc. has undergone a strategic transformation, shifting focus from software to financial services and capital markets-related activities, while divesting its software business subsidiary, HeartCore Japan [3][11] - The company reported a significant decrease in revenues for the full year 2025, totaling $9.0 million, down from $22.7 million in 2024, primarily due to the absence of a large Go IPO deal that contributed $13 million in warrant revenue in the previous year [4][18] - Despite the revenue decline, HeartCore achieved a net income of $5.5 million in 2025, compared to a net loss of $5.2 million in 2024, largely due to the gain from the sale of HeartCore Japan [6][18] Financial Performance - Gross profit for 2025 was $3.2 million, a decrease from $14.7 million in 2024, attributed to the lack of significant warrant-related revenue [5][18] - Operating expenses decreased to $6.3 million from $14.9 million in the previous year, reflecting cost-saving measures and the absence of impairment charges [6][18] - Adjusted EBITDA for 2025 was $6.5 million, down from $7.3 million in 2024, indicating a slight decline in operational performance [7][18] Operational Highlights - As of March 31, 2026, HeartCore was engaged with 16 Go IPO clients, with 6 clients in various stages of preparation for public registrations and U.S. exchange listings [11] - The establishment of Higgs Field in Q4 2025 marks a new operating platform in Japan, supporting the company's strategic transition towards financial services [3][11] - The company authorized a $2.0 million share repurchase program and a one-time distribution payment to stockholders, indicating a commitment to returning value to shareholders [11]

Core Viewpoint - Plus Therapeutics, Inc. has granted inducement awards to two new employees as part of its strategy to attract talent in the healthcare sector focused on CNS cancers [1][2]. Inducement Awards - The inducement awards were granted on March 26, 2026, under the Company's 2015 New Employee Incentive Plan, totaling options to purchase 300,000 shares of common stock and 300,000 restricted stock units (RSUs) [2]. - The options have a 10-year term with an exercise price of $0.243, which is the fair market value on the grant date, and vest over a four-year period [3]. - Each RSU represents a right to receive one share of common stock, vesting over three years with 1/3 vesting on the first anniversary and the remainder vesting ratably over the next eight quarters [4]. Approval and Compliance - The awards were approved by the Compensation Committee of the Company's board of directors, in compliance with Nasdaq Rule 5635(c)(4) [5]. Company Overview - Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Houston, Texas, focused on developing targeted radiotherapeutics for challenging CNS cancers [7]. - The company is advancing a pipeline of product candidates, particularly in leptomeningeal metastases and recurrent glioblastoma, utilizing image-guided local beta radiation and targeted drug delivery [7]. - Plus Therapeutics has established a supply chain through strategic partnerships to support the development, manufacturing, and potential commercialization of its products [7].

Core Viewpoint - THOR Industries has appointed Andy Murray as Senior Vice President of Strategy and Business Development to enhance supply chain capabilities and long-term value creation in the RV industry [1][3][8]. Group 1: Appointment and Background - Andy Murray brings over 20 years of executive experience from LCI Industries, where he served as Chief Sales Officer [2]. - His reputation in the RV and specialty manufacturing industries is well-established, which is expected to benefit THOR [2][3]. Group 2: Strategic Focus - In his new role, Murray will enhance operational and financial performance, identify growth opportunities, and strengthen collaboration across the RV ecosystem [3][7]. - THOR aims to leverage its scale and relationships to improve performance, innovation, and reliability in the supply chain [4][5]. Group 3: Commitment to the RV Industry - THOR's strategy is dedicated solely to the RV industry, aligning its interests with those of its supply customers [5]. - Recent investments, such as the acquisition of Synergy Design, LLC, reflect THOR's commitment to expanding capabilities for RV OEMs [6]. Group 4: Future Opportunities - Murray emphasizes the significant opportunities ahead for THOR in strengthening its supply chain capabilities and driving performance [7]. - The creation of this role signifies THOR's ongoing investment in its capabilities and positioning for sustainable growth [8].

Core Insights - SmartStop Self Storage REIT, Inc. announced that Executive Vice President Bliss Edwards will participate as a panelist at the Vancouver Real Estate Forum, scheduled for March 31-April 1, 2026 [1][4] Company Overview - SmartStop Self Storage REIT, Inc. is an internally managed real estate investment trust focused on self-storage facilities in the U.S. and Canada, with a portfolio of over 460 operating properties across 35 states, Washington, D.C., and Canada, totaling more than 270,000 units and over 35 million rentable square feet as of March 31, 2026 [2][4] - The company also manages 50 self-storage properties in Canada, comprising approximately 43,000 units and 4.3 million rentable square feet [2] Industry Participation - Bliss Edwards will join a panel discussion titled "Exploring Alternative Assets: From Self-Storage and Seniors & Student Housing to Data Centers – Where Are Investors Flocking Next?" on April 1, 2026, at 1:15 p.m. Pacific Time [2]

Core Insights - Axe Compute Inc. has successfully transformed into a GPU compute infrastructure and digital asset treasury company, raising $343.5 million in capital to support its strategic initiatives [1][2] Financial Highlights - For the fiscal year ended December 31, 2025, total revenue was $125,284, entirely from the legacy Drug Discovery Services segment, with no revenue from the new compute segment [3][12] - The company reported a net loss from continuing operations of $232.9 million, which includes significant non-cash charges such as $152.5 million in unrealized losses on digital assets [12] - As of December 31, 2025, the company had $10.8 million in cash and cash equivalents, with total assets amounting to $52.9 million, a substantial increase from $5.0 million in the previous year [10][11] Strategic Developments - The company launched a Strategic Compute Reserve focused on the ATH token, holding approximately 6.348 billion ATH by year-end 2025 [4] - A leadership transition occurred with Christopher Miglino appointed as CEO, bringing over 25 years of experience in technology and digital asset sectors [4][2] - The company established access to a distributed GPU network of over 435,000 GPUs across more than 200 locations, enabling enterprise-scale AI workloads [4][16] Market Context - The global AI spending is projected to reach $2.52 trillion in 2026, representing a 44% year-over-year increase, with a significant portion of data center spending expected to be GPU-related [5] - North American data center vacancy rates are at a record low of 1.6%, indicating a supply-demand imbalance that presents a commercial opportunity for Axe Compute's distributed GPU model [5] Operational Priorities for 2026 - The company aims to deploy compute capacity to enterprise customers, generate initial revenue from Compute Services, and pursue ATH staking activities to yield returns on treasury holdings [7] - Ongoing strategic alternatives are being explored for the Helomics legacy business, including potential sale or partnership options [7]

Core Viewpoint - CoinShares International Limited has announced a merger with Vine Hill Capital Investment Corp and Odysseus Holdings, which will facilitate a change of listing venue for CoinShares shares from Nasdaq Stockholm to the Nasdaq Stock Market in the United States [1] Group 1: Transaction Details - The merger plan includes a court-sanctioned scheme of arrangement under Article 125 of the Jersey Companies Law [1] - The Scheme of Arrangement has become effective, with the entire issued share capital of CoinShares now owned by Odysseus Cayman [3] - Nasdaq has approved the listing of the New Odysseus Holdings Shares, satisfying the conditions outlined in the Scheme Circular [4] Group 2: Shareholder Information - Shareholders of CoinShares will receive 1.8237 New Odysseus Holdings Shares for each CoinShares Share held, except for PIPE Shares, which will receive 1 New Odysseus Holdings Share [6] - A total of 1,139,537 CoinShares Shares held in treasury have been cancelled as part of the transaction [13] Group 3: Listing and Trading - Nasdaq Stockholm will proceed with the delisting of CoinShares Shares following the effectiveness of the Scheme of Arrangement [8] - Trading of the New Odysseus Holdings Shares on Nasdaq is expected to commence on or around 1 April 2026 [9] Group 4: PIPE Investment - An institutional investor has agreed to subscribe for 5,000,000 CoinShares Shares for a total purchase price of $50 million, with additional shares issued as a commitment fee [10] - The PIPE Investor held 102,020 Class A ordinary shares of Vine Hill, allowing for a reduction in the number of PIPE Investment Shares purchased [11] Group 5: Company Name Change - Odysseus Holdings has been re-registered as a public limited company and renamed CoinShares PLC, effective as of 31 March 2026 [12]

Core Viewpoint - Portofino Resources Inc. has reported the expiration of approximately 173 claim cells associated with the South of Otter Project due to insufficient capital for exploration activities, but has subsequently entered into a Property Option Agreement to acquire these and additional cells [1][2]. Group 1: Project and Claims - The expired claim cells were part of the South of Otter Project and expired on March 4, 2026, due to the company's lack of capital for required exploration activities [1]. - Following the expiration, the company entered into an agreement with an arms-length party to stake the expired cells along with approximately 180 additional contiguous cells [2]. Group 2: Transaction Details - To earn a 100% interest in the project, Portofino will issue 6,000,000 common shares upon approval from the TSX Venture Exchange and make cash payments totaling $90,000 over a 3-year period [3]. - The payment schedule includes an initial cash payment of $15,000, followed by $18,000 by the first anniversary, $25,000 by the second anniversary, and $32,000 by the third anniversary of the agreement's effective date [7]. Group 3: Company Overview - Portofino Resources Inc. is based in Vancouver, Canada, and focuses on exploring and developing mineral resource projects in the Americas [4]. - The company holds a 100% interest in the Yergo Lithium Project in Argentina and two gold exploration projects in northwestern Ontario, including the South of Otter Project [4].

Core Insights - Academy Sports + Outdoors plans to host an Analyst Day event on April 7, 2026, to discuss long-term strategy and growth initiatives [1][2] Group 1: Event Details - The Analyst Day will begin at 9:00 a.m. Eastern Time, featuring presentations from CEO Steve Lawrence, CFO Carl Ford, and Chief Customer Officer Chad Fox [2] - A live webcast of the event will be available on the company's website, with presentation materials posted prior to the event and a replay archived for approximately 30 days [2][3] Group 2: Company Overview - Academy Sports + Outdoors is a leading full-line sporting goods and outdoor recreation retailer in the U.S., with over 300 stores across 21 states [4] - The company's mission is to provide "Fun for All," supported by a localized merchandising strategy and a diverse product assortment in outdoor, apparel, sports & recreation, and footwear categories [4]

Core Viewpoint - Flexible Solutions International, Inc. has announced a delay in releasing its full year 2025 financials due to late comments from tax consultants [1][2] Company Overview - Flexible Solutions International, Inc. is based in Taber, Alberta, and specializes in biodegradable polymers for various applications including oil extraction, detergent ingredients, water treatment, and crop nutrient availability [1][2] - The company also manufactures environmentally safe technologies for water and energy conservation and is expanding into the food and nutrition supplement manufacturing markets [1] Financial Delay - The delay in financial reporting is attributed to the tax consultants being late with their comments, and the company will release the audited financials once the auditor completes the analysis [2] - A date and details for a conference call will be announced alongside the release of the financials [2] Product Specialization - The company's subsidiary, NanoChem Solutions Inc., focuses on biodegradable, water-soluble products made from thermal polyaspartate (TPA) biopolymers, which have applications in scale inhibition, detergents, water treatment, and crop enhancement [2] - In 2022, the company entered the food and nutrition markets by obtaining FDA food grade approval for its Peru IL plant [2]

Core Viewpoint - Tantech Holdings Ltd has successfully completed a registered direct offering and private placements, raising approximately $2.15 million through the issuance of Common Shares and Warrants [1][2]. Group 1: Offering Details - The transactions involved the sale of 7,166,671 Common Units, each consisting of one Common Share, one Series E Common Warrant (exercisable for three Common Shares at $0.30 per share), and one Series F Common Warrant (exercisable for three Common Shares at $0.35 per share) [2]. - The offering price per Common Unit was set at $0.30, leading to aggregate gross proceeds of approximately $2.15 million [2]. Group 2: Use of Proceeds - The Company plans to utilize the net proceeds from the offerings, along with existing cash, for general corporate purposes and working capital [2]. Group 3: Regulatory Compliance - The registered direct offering was conducted under an effective shelf registration statement on Form F-3, which was declared effective by the SEC on September 11, 2023 [4]. - The securities offered in the private placement were made under Regulation S of the Securities Act, and are not registered under the Securities Act or applicable state laws, limiting their resale in the U.S. [4].